Active Ingredient: LIFITEGRAST
Proprietary Name: LIFITEGRAST
Dosage Form; Route of Administration: SOLUTION/DROPS; OPHTHALMIC
Strength: 5%
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A215063
Product Number: 001
Approval Date: Nov 7, 2023
Applicant Holder Full Name: EUGIA PHARMA SPECIALITIES LTD
Marketing Status:
Discontinued
Patent and Exclusivity Information